Symbols

BBNX

Beta Bionics·NASDAQ

--(--)

BBNX fundamentals

BBNX Q1 2026 Earnings Preview

Beta Bionics (BBNX) expects to report earnings on Apr 21, 2026, with estimated revenue of 26.96M (YoY +52.86%), and EPS at -0.5027 (YoY +45.95%).

Revenue estimate / YoY

26.96M

+52.86%

EPS estimate / YoY

-0.5027

+45.95%

Report date

Apr 21, 2026

Earnings Call

4:30 PM on Apr 21, 2026

Meeting link.

Earnings

EPS

Revenue

Revenue & Expenses

BBNX has released its 2025 Q4 earnings report, with revenue of 32.12M, reflecting a YoY change of 57.15%, and net profit of -13.47M, showing a YoY change of 25.64%. The Sankey diagram below clearly presents BBNX's revenue sources and cost distribution.

Key Indicators

Beta Bionics (BBNX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Beta Bionics (BBNX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Beta Bionics (BBNX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Beta Bionics (BBNX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown